Hot Pursuit     20-Dec-21
Biocon Ltd continues to fall
Biocon Ltd is quoting at Rs 347.25, down 1.7% on the day as on 13:24 IST on the NSE. The stock tumbled 22.83% in last one year as compared to a 23.81% rally in NIFTY and a 6.5% spurt in the Nifty Pharma index.

Biocon Ltd is down for a fifth straight session today. The stock is quoting at Rs 347.25, down 1.7% on the day as on 13:24 IST on the NSE. The benchmark NIFTY is down around 2.84% on the day, quoting at 16502. The Sensex is at 55491.94, down 2.67%.Biocon Ltd has lost around 2.96% in last one month.Meanwhile, Nifty Pharma index of which Biocon Ltd is a constituent, has eased around 1.27% in last one month and is currently quoting at 13230.7, down 1.16% on the day. The volume in the stock stood at 10.77 lakh shares today, compared to the daily average of 28.78 lakh shares in last one month.

The benchmark December futures contract for the stock is quoting at Rs 349.9, down 0.99% on the day. Biocon Ltd tumbled 22.83% in last one year as compared to a 23.81% rally in NIFTY and a 6.5% spurt in the Nifty Pharma index.

The PE of the stock is 342.67 based on TTM earnings ending September 21.

Previous News
  Biocon's new monoclonal antibodies facility in India get manufacturing approval from EMA
 ( Hot Pursuit - 24-Jun-24   09:34 )
  Biocon Biologics receives GMP certifications for its Indian and Malaysian manufacturing units
 ( Corporate News - 24-Jun-24   09:01 )
  Biocon consolidated net profit rises 550.59% in the June 2024 quarter
 ( Results - Announcements 09-Aug-24   07:32 )
  Biocon AGM scheduled
 ( Corporate News - 17-May-24   13:47 )
  USFDA classifies inspection of Biocon Biologic's Malaysian unit as 'OAI'
 ( Corporate News - 18-Oct-23   09:28 )
  Biocon Biologics divests its non-crore branded formulations biz in India
 ( Corporate News - 10-Nov-23   12:06 )
  Biocon
 ( Results - Analysis 16-Feb-23   10:55 )
  Biocon 's biologics subsidiary gets European Commission's nod for Aflibercept biosimilar
 ( Hot Pursuit - 21-Sep-23   09:24 )
  Board of Biocon to consider NCD issuance and investment in Biocon Biologics
 ( Corporate News - 24-Apr-23   09:50 )
  Biocon's subsidiary receives UK’s MHRA approval for Aflibercept biosimilar
 ( Hot Pursuit - 13-Nov-23   17:05 )
  Indices trade with decent gains; realty shares rallied for 5th day
 ( Market Commentary - Mid-Session 17-May-24   12:40 )
Other Stories
  Tata Motors total sales drop 11% YoY in Sept’24
  01-Oct-24   15:33
  Vipul Organics hits all-time high after board OKs Rs 25 cr right issue
  01-Oct-24   15:06
  Magellanic Cloud Ltd leads losers in 'A' group
  01-Oct-24   15:00
  Kamdhenu Ventures Ltd leads losers in 'B' group
  01-Oct-24   14:45
  GE Power India rises on bagging order worth Rs 240-cr
  01-Oct-24   14:41
  Volumes jump at Caplin Point Laboratories Ltd counter
  01-Oct-24   14:30
  TVS Motor registers 20% growth in September 2024 sales; Q2 total sales at 12.28 lakh units
  01-Oct-24   14:07
  Oil and Gas shares slide
  01-Oct-24   14:00
  Telecom shares fall
  01-Oct-24   14:00
  Real Estate stocks slide
  01-Oct-24   14:00
Back Top